Biogen Idec Inc. (NASDAQ:BIIB): Current Price: $161.42
Biogen acquired Elan’s (NYSE:ELN) stake in Tysabri, causing RBC Capital to believe that the deal makes sense from a strategic financial perspective, due to the fact that it will raise Biogen’s margins and lower its tax rate. The firm is convinced that Biogen’s SG&A as a percentage of revenue will decline following the deal and it reiterates its Outperform rating on the stock.
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More
There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more
At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more